✨ Medicine Consent Notices




7 FEBRUARY 2013 NEW ZEALAND GAZETTE, No. 13 449

Product: Adacel Polio
Active Ingredients:

  • Diphtheria toxoid, adsorbed 2IU
  • Pertactin 3mcg
  • Pertussis filamentous haemagglutinin 5mcg
  • Pertussis fimbriae 2+3 5mcg
  • Pertussis toxoid, adsorbed 2.5mcg
  • Polio virus type 1 40DAgU
  • Polio virus type 2 8DAgU
  • Polio virus type 3 32DAgU
  • Tetanus toxoid 20IU
    Dosage Form: Suspension for injection
    New Zealand Sponsor: sanofi-aventis new zealand limited
    Manufacturers:
  • Sanofi Pasteur SA, Marcy L’Etoile, France
  • Sanofi Pasteur Limited, Ontario, Canada

Product: Pediacel
Active Ingredients:

  • Diphtheria toxoid, adsorbed 15Lf U
  • Haemophilus influenzae type b polysaccharide 10mcg
  • Pertactin 3mcg
  • Pertussis filamentous haemagglutinin 20mcg
  • Pertussis fimbriae 2+3 5mcg
  • Pertussis toxoid, adsorbed 20mcg
  • Polio virus type 1 40DAgU
  • Polio virus type 2 8DAgU
  • Polio virus type 3 32DAgU
  • Tetanus toxoid 20mcg
  • Tetanus toxoid, adsorbed 5Lf U
    Dosage Form: Suspension for injection
    New Zealand Sponsor: sanofi-aventis new zealand limited
    Manufacturer: Sanofi Pasteur Limited, Ontario, Canada

Product: Poliacel (Combination Product)
Active Ingredients:

  • Diphtheria toxoid, adsorbed 15Lf U
  • Pertactin 3mcg
  • Pertussis filamentous haemagglutinin 20mcg
  • Pertussis fimbriae 2+3 5mcg
  • Pertussis toxoid, adsorbed 20mcg
  • Polio virus type 1 40DAgU
  • Polio virus type 2 8DAgU
  • Polio virus type 3 32DAgU
  • Tetanus toxoid, adsorbed 5Lf U
    Dosage Form: Quadracel component Suspension for injection
    Active Ingredient: Haemophilus influenzae type b polysaccharide 10mcg
    Dosage Form: Act-HIB component Powder for injection
    New Zealand Sponsor: sanofi-aventis new zealand limited
    Manufacturer: Sanofi Pasteur Limited, Ontario, Canada

Product: Quadracel
Active Ingredients:

  • Diphtheria toxoid, adsorbed 15Lf U
  • Pertactin 3mcg
  • Pertussis filamentous haemagglutinin 20mcg
  • Pertussis fimbriae 2+3 5mcg
  • Pertussis toxoid, adsorbed 20mcg
  • Polio virus type 1 40DAgU
  • Polio virus type 2 8DAgU
  • Polio virus type 3 32DAgU
  • Tetanus toxoid, adsorbed 5Lf U
    Dosage Form: Suspension for injection
    New Zealand Sponsor: sanofi-aventis new zealand limited
    Manufacturer: Sanofi Pasteur Limited, Ontario, Canada


Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2013, No 13





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
31 January 2013
Medicines Act 1981, New Medicine Consent, Adacel Polio, Vaccine

πŸ₯ Consent to the Distribution of Pediacel

πŸ₯ Health & Social Welfare
31 January 2013
Medicines Act 1981, New Medicine Consent, Pediacel, Vaccine

πŸ₯ Consent to the Distribution of Poliacel

πŸ₯ Health & Social Welfare
31 January 2013
Medicines Act 1981, New Medicine Consent, Poliacel, Vaccine

πŸ₯ Consent to the Distribution of Quadracel

πŸ₯ Health & Social Welfare
31 January 2013
Medicines Act 1981, New Medicine Consent, Quadracel, Vaccine